KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.23, sa.4, ss.294-304, 2013 (SCI-Expanded)
Objective: Cognitive impairments in schizophrenia are associated with different symptom subtypes of schizophrenia. It has been suggested that cognitive functions in the paranoid type of schizophrenia were better protected. Here, we examine how neuropsychological measures jointly differentiate patients with paranoid schizophrenia from non-paranoid patients.